Compendium of Cancer Genome Aberrations

Changes

HAEM5:Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder (view source)

Revision as of 13:35, 11 June 2024

599 bytes removed ,  11 June
→‎Chromosomal Rearrangements (Gene Fusions)
Line 91: Line 91:  
!Notes
 
!Notes
 
|-
 
|-
−
|<span class="blue-text">EXAMPLE:</span> t(9;22)(q34;q11.2)||<span class="blue-text">EXAMPLE:</span> 3'ABL1 / 5'BCR||<span class="blue-text">EXAMPLE:</span> der(22)||<span class="blue-text">EXAMPLE:</span> 20% (COSMIC)
+
|Not found||N/A||N/A||N/A
−
<span class="blue-text">EXAMPLE:</span> 30% (add reference)
+
|N/A
−
|<span class="blue-text">EXAMPLE:</span> Yes
+
|N/A
−
|<span class="blue-text">EXAMPLE:</span> No
+
|N/A
−
|<span class="blue-text">EXAMPLE:</span> Yes
+
|N/A
−
|<span class="blue-text">EXAMPLE:</span>
  −
The t(9;22) is diagnostic of CML in the appropriate morphology and clinical context (add reference). This fusion is responsive to targeted therapy such as Imatinib (Gleevec) (add reference).
   
|}
 
|}
 
==Individual Region Genomic Gain / Loss / LOH==
 
==Individual Region Genomic Gain / Loss / LOH==
Amanda.Xu
13

edits

Retrieved from "https://ccga.io/index.php/Special:MobileDiff/14471"